The global healthcare sector is prioritizing rapid pathogen identification to mitigate the impact of seasonal epidemics. As respiratory infections become more complex, the Influenza Diagnostics Market Share is increasingly shifting toward high-sensitivity molecular platforms and integrated testing solutions. This evolution is driven by the need for clinical accuracy and the rising integration...